Back
BioXcel Therapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
20
BTAI
BioXcel Therapeutics
Last Price:
$1.45
Seasonality Move:
-13.11%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.53 | Sell |
| 20-day SMA: | 1.7 | Sell |
| 50-day SMA: | 1.98 | Sell |
| 200-day SMA: | 6.58 | Sell |
| 8-day EMA: | 1.52 | Sell |
| 20-day EMA: | 1.67 | Sell |
| 50-day EMA: | 2.16 | Sell |
| 200-day EMA: | 12.04 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 32.83 | Sell |
| Chaikin Money Flow: | -75124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.56 - 1.88) | Sell |
| Bollinger Bands (100): | (1.45 - 5.13) | Sell |
BioXcel Therapeutics Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.37 while BTAI 8-day simple moving average is 1.53, which is a Sell signal.
-
The stock price of BTAI is 1.37 while BioXcel Therapeutics 20-day SMA is 1.70, which makes it a Sell.
-
BioXcel Therapeutics 50-day simple moving average is 1.98 while BTAI share price is 1.37, making it a Sell technically.
-
BTAI stock price is 1.37 and BioXcel Therapeutics 200-day simple moving average is 6.58, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
20
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.37. The Score for BTAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
7.5M
Price in USD:
1.37
Share Volume:
156K
BioXcel Therapeutics 52-Week Range
52-Week High:
35.68
52-Week Low:
1.29
Sell
20
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.37 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.37 while BTAI 8-day exponential moving average is 1.52, which is a Sell signal.
-
The stock price of BTAI is 1.37 while BioXcel Therapeutics 20-day EMA is 1.67, which makes it a Sell.
-
BioXcel Therapeutics 50-day exponential moving average is 2.16 while BTAI share price is 1.37, making it a Sell technically.
-
BTAI stock price is 1.37 and BioXcel Therapeutics 200-day simple moving average is 12.04, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.65 per share, and a decrease next year of $7.26 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting BioXcel Therapeutics is a Sell
-
BioXcel Therapeutics Relative Strength Index (RSI) is 32.83, which suggest BioXcel Therapeutics is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.56 - 1.88), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.45 - 5.13), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.